6.16
전일 마감가:
$6.51
열려 있는:
$6.45
하루 거래량:
76,495
Relative Volume:
0.58
시가총액:
$156.81M
수익:
-
순이익/손실:
$-22.38M
주가수익비율:
-4.3688
EPS:
-1.41
순현금흐름:
$-15.54M
1주 성능:
-7.78%
1개월 성능:
-9.68%
6개월 성능:
-20.41%
1년 성능:
-5.23%
Nuvectis Pharma Inc Stock (NVCT) Company Profile
명칭
Nuvectis Pharma Inc
전화
360-837-7232
주소
1 BRIDGE PLAZA, SUITE 275, FORT LEE
NVCT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NVCT
Nuvectis Pharma Inc
|
6.16 | 159.87M | 0 | -22.38M | -15.54M | -1.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-02 | 개시 | Maxim Group | Buy |
2025-03-17 | 개시 | Laidlaw | Buy |
2022-07-13 | 개시 | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc 주식(NVCT)의 최신 뉴스
Tick level data insight on Nuvectis Pharma Inc. volatility2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - Investing News Network
Sentiment analysis tools applied to Nuvectis Pharma Inc.Trade Risk Assessment & Daily Volume Surge Signals - newser.com
How to use Fibonacci retracement on Nuvectis Pharma Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Backtesting results for Nuvectis Pharma Inc. trading strategiesWeekly Risk Summary & Precise Swing Trade Alerts - newser.com
Full technical analysis of Nuvectis Pharma Inc. stockExit Point & AI Powered Buy/Sell Recommendations - Newser
Custom watchlist performance reports with Nuvectis Pharma Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
How high can Nuvectis Pharma Inc. stock goJuly 2025 Macro Moves & Capital Protection Trading Alerts - Newser
Best data tools to analyze Nuvectis Pharma Inc. stockQuarterly Earnings Summary & Community Consensus Stock Picks - Newser
Smart tools for monitoring Nuvectis Pharma Inc.’s price actionJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Should you wait for a breakout in Nuvectis Pharma Inc.2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
Why Nuvectis Pharma Inc. is moving todayMarket Sentiment Report & Real-Time Volume Analysis - Newser
Nuvectis Pharma Inc.’s volatility index tracking explainedWeekly Profit Analysis & Weekly High Return Forecasts - Newser
Will breakout in Nuvectis Pharma Inc. lead to full recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
How to escape a deep drawdown in Nuvectis Pharma Inc.2025 Short Interest & Community Trade Idea Sharing - Newser
What to expect from Nuvectis Pharma Inc. in the next 30 days2025 Trade Ideas & High Conviction Investment Ideas - Newser
Can technical indicators confirm Nuvectis Pharma Inc.’s reversalMarket Weekly Review & Verified Swing Trading Watchlist - Newser
How to recover losses in Nuvectis Pharma Inc. stock2025 Price Action Summary & AI Based Trade Execution Alerts - Newser
Nuvectis Pharma Inc. stock trend outlook and recovery pathMarket Trend Report & Safe Capital Growth Tips - Newser
Combining machine learning predictions for Nuvectis Pharma Inc.Weekly Profit Recap & Verified Momentum Watchlists - Newser
Is Nuvectis Pharma Inc. stock ready for a breakoutEarnings Summary Report & Detailed Earnings Play Alerts - Newser
What recovery options are there for Nuvectis Pharma Inc.Quarterly Performance Summary & Expert-Curated Trade Recommendations - Newser
Tools to monitor Nuvectis Pharma Inc. recovery probability2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Analyzing Nuvectis Pharma Inc. with multi timeframe chartsEarnings Trend Report & Verified Entry Point Signals - Newser
Nuvectis Pharma Inc. stock chart pattern explainedPortfolio Value Summary & Weekly Watchlist of Top Performers - Newser
What earnings revisions data tells us about Nuvectis Pharma Inc.Quarterly Investment Review & Reliable Breakout Forecasts - Newser
Nuvectis Pharma Inc. recovery potential after sell off2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Using AI based signals to follow Nuvectis Pharma Inc.Weekly Investment Summary & AI Powered Trade Plan Recommendations - Newser
Is Nuvectis Pharma Inc. still worth holding after the dipJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
What Fibonacci levels say about Nuvectis Pharma Inc. reboundPortfolio Performance Report & Weekly Breakout Stock Alerts - Newser
What MACD signals say about Nuvectis Pharma Inc.Trend Reversal & Daily Momentum Trading Reports - Newser
Is Nuvectis Pharma Inc. stock entering bullish territoryMarket Growth Review & Low Drawdown Investment Ideas - Newser
Price action breakdown for Nuvectis Pharma Inc.Market Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Earnings Growth Summary & Daily Technical Forecast Reports - Newser
Nuvectis Pharma Inc (NVCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):